![](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2025836701/image_2025836701.jpg?io=getty-c-w1536)
Novo Nordisk: Low Dividend Yield, Decelerated Growth Rates, Hold For Now
aprott Article Thesis Novo Nordisk A/S (NVO) has turned into one of the most valuable pharma companies in the world thanks to its success with weight loss drug Wegovy. But growth has recently slowed down, and the company's valuation is quite high. …